Global Nuclear Imaging Equipment Market Report and Forecast 2023-2031

Global Nuclear Imaging Equipment Market Report and Forecast 2023-2031


Global Nuclear Imaging Equipment Market Outlook

The global nuclear imaging equipment market value was USD 2.8 billion in 2022, driven by the increasing prevalence of chronic diseases across the globe. The market size is anticipated to grow at a CAGR of 5.62% during the forecast period of 2023-2031 to achieve a value of USD 4.5 billion by 2031.

Nuclear Imaging Equipment: Introduction

Nuclear imaging equipment refers to a range of medical devices used in nuclear medicine procedures for diagnostic imaging and treatment purposes. These devices utilize radioactive substances known as radiotracers or radiopharmaceuticals to create images of various organs and body functions. Nuclear imaging techniques include single-photon emission computed tomography (SPECT) and positron emission tomography (PET). The introduction of nuclear imaging equipment has revolutionized the field of medical imaging by providing valuable insights into the functioning and metabolism of organs at a molecular level. These imaging techniques are particularly useful in diagnosing and monitoring various conditions such as cancer, cardiovascular diseases, neurological disorders, and skeletal abnormalities.

Key Trends in the Global Nuclear Imaging Equipment Market

Key trends in the nuclear imaging equipment market include advancements in technology, such as the development of hybrid imaging systems that combine PET and CT (computed tomography) or SPECT and CT capabilities. These hybrid systems allow for more precise and accurate imaging, facilitating better diagnosis and treatment planning. Another trend is the integration of artificial intelligence (AI) and machine learning algorithms into nuclear imaging equipment. AI algorithms can assist in image interpretation, improving the accuracy of diagnoses and reducing the time required for analysis. AI also enables automated image processing and reconstruction, enhancing workflow efficiency. There is also a growing focus on radiation dose reduction in nuclear imaging. Manufacturers are developing techniques and technologies to minimize radiation exposure to patients while maintaining image quality. This includes the use of low-dose imaging protocols, optimized radiotracer dosing, and advanced reconstruction algorithms.

There is also a growing focus on radiation dose reduction in nuclear imaging. Manufacturers are developing techniques and technologies to minimize radiation exposure to patients while maintaining image quality. This includes the use of low-dose imaging protocols, optimized radiotracer dosing, and advanced reconstruction algorithms. Emerging economies, such as China, India, and Brazil, are witnessing significant growth in the healthcare sector and are increasing their investments in medical imaging infrastructure. The rising healthcare expenditure, improving healthcare facilities, and growing awareness about advanced diagnostic techniques drive the demand for nuclear imaging equipment in these markets. Manufacturers are targeting these regions to expand their customer base and tap into the growing opportunities.

Global Nuclear Imaging Equipment Market Segmentations

Market Breakup by Type
  • Gamma Camera Imaging Systems
  • SPECT Imaging Systems
  • Planar Scintigraphy Imaging Systems
  • PET Imaging Systems
Market Breakup by Applications
  • Oncology
  • Cardiology
  • Neurology
  • Others
  • Urology
  • Orthopedics
  • Gastroenterology
  • Thyroid-Related Disorders
  • Others
Market Breakup by End User
  • Hospitals and Clinics
  • Diagnostic Imaging Centers
  • Specialty Clinics
  • Others
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Nuclear Imaging Equipment Market Scenario

The global market is expected to witness significant growth in the coming years. Several factors contribute to the positive market outlook, including the increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, the growing demand for non-invasive diagnostic techniques, and advancements in imaging technology.

One key driver of market growth is the rising incidence of cancer worldwide. Nuclear imaging plays a crucial role in cancer diagnosis, staging, and treatment planning. With the increasing adoption of nuclear imaging techniques, such as PET/CT and SPECT/CT, healthcare providers can obtain more accurate and detailed information about tumour location, size, and activity, leading to improved patient outcomes.

Cardiovascular diseases are another major driver for the nuclear imaging equipment market. Nuclear imaging techniques provide valuable insights into heart function, blood flow, and myocardial perfusion, aiding in the diagnosis and management of various cardiac conditions. The rising prevalence of heart diseases, coupled with the growing aging population, contributes to the demand for nuclear imaging equipment in the cardiology field.

Geographically, North America and Europe dominate the nuclear imaging equipment market due to well-established healthcare infrastructure, higher healthcare expenditure, and early adoption of advanced imaging technologies. However, emerging economies in Asia Pacific, Latin America, and the Middle East are expected to witness significant market growth due to improving healthcare infrastructure, increasing investments in healthcare, and rising awareness about the benefits of nuclear imaging.

Global Nuclear Imaging Equipment Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • Siemens Healthineers AG
  • GE Healthcare
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Star Equity Holdings, Inc.
  • SurgicEye GmbH
  • Mediso Ltd.
  • Rigaku Corporation (MILabs B.V.)
  • MR Solutions Ltd.
  • DDD - Diagnostics A/S
  • Segami Corporation
  • Mirion Technologies (Capintec), Inc.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd.
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

*Please Note:* The report will take 7 business days to complete, after order confirmation.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Nuclear Imaging Equipment Market Overview
3.1 Global Nuclear Imaging Equipment Market Historical Value (2016-2022)
3.2 Global Nuclear Imaging Equipment Market Forecast Value (2023-2031)
4 Global Nuclear Imaging Equipment Market Dynamics
4.1 Market Drivers and Constraints
4.2 SWOT Analysis
4.3 Porter’s Five Forces Model
4.4 Key Demand Indicators
4.5 Key Price Indicators
4.6 Industry Events, Initiatives, and Trends
4.7 Value Chain Analysis
5 Global Nuclear Imaging Equipment Market Segmentation
5.1 Global Nuclear Imaging Equipment Market by Type
5.1.1 Market Overview
5.1.2 Gamma Camera Imaging Systems
5.1.2.1 SPECT Imaging Systems
5.1.2.2 Planar Scintigraphy Imaging Systems
5.1.3 PET Imaging Systems
5.2 Global Nuclear Imaging Equipment Market by Applications
5.2.1 Market Overview
5.2.2 Oncology
5.2.3 Cardiology
5.2.4 Neurology
5.2.5 Urology
5.2.6 Orthopedics
5.2.7 Gastroenterology
5.2.8 Thyroid-Related Disorders
5.2.9 Others
5.3 Global Nuclear Imaging Equipment Market by End User
5.3.1 Market Overview
5.3.2 Hospitals and Clinics
5.3.3 Diagnostic Imaging Centers
5.3.4 Specialty Clinics
5.3.5 Others
5.4 Global Nuclear Imaging Equipment Market by Region
5.4.1 Market Overview
5.4.2 North America
5.4.3 Europe
5.4.4 Asia Pacific
5.4.5 Latin America
5.4.6 Middle East and Africa
6 North America Nuclear Imaging Equipment Market
6.1 Market Share by Country
6.2 United States of America
6.3 Canada
7 Europe Nuclear Imaging Equipment Market
7.1 Market Share by Country
7.2 United Kingdom
7.3 Germany
7.4 France
7.5 Italy
7.6 Others
8 Asia Pacific Nuclear Imaging Equipment Market
8.1 Market Share by Country
8.2 China
8.3 Japan
8.4 India
8.5 ASEAN
8.6 Australia
8.7 Others
9 Latin America Nuclear Imaging Equipment Market
9.1 Market Share by Country
9.2 Brazil
9.3 Argentina
9.4 Mexico
9.5 Others
10 Middle East and Africa Nuclear Imaging Equipment Market
10.1 Market Share by Country
10.2 Saudi Arabia
10.3 United Arab Emirates
10.4 Nigeria
10.5 South Africa
10.6 Others
11 Patent Analysis
11.1 Analysis by Type of Patent
11.2 Analysis by Publication year
11.3 Analysis by Issuing Authority
11.4 Analysis by Patent Age
11.5 Analysis by CPC Analysis
11.6 Analysis by Patent Valuation
11.7 Analysis by Key Players
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Siemens Healthineers AG
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisitions
16.1.5 Certifications
16.2 GE Healthcare
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Koninklijke Philips N.V.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Canon Medical Systems Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Star Equity Holdings, Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 SurgicEye GmbH
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Mediso Ltd.
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Rigaku Corporation (MILabs B.V.)
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 MR Solutions Ltd.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 DDD - Diagnostics A/S
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
16.11 Segami Corporation
16.11.1 Financial Analysis
16.11.2 Product Portfolio
16.11.3 Demographic Reach and Achievements
16.11.4 Mergers and Acquisitions
16.11.5 Certifications
16.12 Mirion Technologies (Capintec), Inc.
16.12.1 Financial Analysis
16.12.2 Product Portfolio
16.12.3 Demographic Reach and Achievements
16.12.4 Mergers and Acquisitions
16.12.5 Certifications
16.13 Positron Corporation
16.13.1 Financial Analysis
16.13.2 Product Portfolio
16.13.3 Demographic Reach and Achievements
16.13.4 Mergers and Acquisitions
16.13.5 Certifications
16.14 Neusoft Medical Systems Co., Ltd.
16.14.1 Financial Analysis
16.14.2 Product Portfolio
16.14.3 Demographic Reach and Achievements
16.14.4 Mergers and Acquisitions
16.14.5 Certifications
17 Global Nuclear Imaging Equipment Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings